CCCC - C4 Therapeutics, Inc.

QQQ $ 620.25 $ 1.46 (0.24 %)

DIA $ 471.63 $ -0.22 (-0.05 %)

SPY $ 678.15 $ 0.96 (0.14 %)

TLT $ 89.52 $ 0.04 (0.04 %)

GLD $ 375.41 $ -0.55 (-0.15 %)

Previous Close

$ 2.34

Open

$ 2.39

Bid

$ 2.35 x 591

Ask

$ 2.37 x 900

Day's Range

$ 2.36 - $ 2.41

52 Week Range

$ 1.09 - $ 6.20

Volume

1,190,954

Average Volume

Market Cap

226.78M

Beta (5Y Monthly)

$ 2.51

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-06-2025	09-30-2025	10-Q
2	08-07-2025	06-30-2025	10-Q
3	05-07-2025	03-31-2025	10-Q
4	02-27-2025	01-01-1970	10-K
5	10-31-2024	09-30-2024	10-Q
6	08-01-2024	06-30-2024	10-Q
7	05-08-2024	03-31-2024	10-Q
8	02-22-2024	12-31-2023	10-K
9	11-01-2023	09-30-2023	10-Q
10	08-08-2023	06-30-2023	10-Q
11	05-04-2023	03-31-2023	10-Q
12	02-23-2023	12-31-2022	10-K
13	11-03-2022	09-30-2022	10-Q
14	08-04-2022	06-30-2022	10-Q
15	05-05-2022	03-31-2022	10-Q
16	02-24-2022	12-31-2021	10-K
17	11-10-2021	09-30-2021	10-Q
18	08-11-2021	06-30-2021	10-Q
19	05-13-2021	03-31-2021	10-Q
20	03-11-2021	12-31-2020	10-K
21	11-12-2020	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

C4 Therapeutics Q3 EPS $(0.44) Misses $(0....
11/06/2025 12:10:12

C4 Therapeutics (NASDAQ:CCCC) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0...

C4 Therapeutics 13G Filing Shows Point72 A...
10/20/2025 22:19:22

- SEC Filing

C4 Therapeutics Priced An Underwritten Off...
10/16/2025 11:10:08

12 Health Care Stocks Moving In Friday's P...
10/03/2025 12:08:34

C4 Therapeutics Announces Clinical Trial C...
10/01/2025 11:03:16

Wells Fargo Maintains Overweight on C4 The...
09/23/2025 12:43:52

Wells Fargo analyst Derek Archila maintains C4 Therapeutics (NASDAQ:CCCC) with a Overweight and raises the price target from...

12 Health Care Stocks Moving In Monday's I...
09/22/2025 17:06:11

Forecasting The Future: 4 Analyst Projecti...
09/22/2025 13:01:10

Stephens & Co. Reiterates Overweight on C4...
09/22/2025 12:22:16

Stephens & Co. analyst Sudan Loganathan reiterates C4 Therapeutics (NASDAQ:CCCC) with a Overweight and maintains $6 pric...

$reported-saturday-c4-therapeutics-reports-phase-1-cemsidomide-data-showing-50-response-rate-in-relapsed-refractory-multiple-myeloma-at-international-myeloma-society-meeting$

Reported Saturday, C4 Therapeutics Reports...
09/22/2025 06:54:04

Barclays Initiates Coverage On C4 Therapeu...
09/17/2025 10:49:28

Barclays analyst Etzer Darout initiates coverage on C4 Therapeutics (NASDAQ:CCCC) with a Overweight rating and announces Pri...

12 Health Care Stocks Moving In Monday's I...
09/15/2025 17:06:06

Stephens & Co. Upgrades C4 Therapeutics to...
09/15/2025 13:39:06

Stephens & Co. analyst Sudan Loganathan upgrades C4 Therapeutics (NASDAQ:CCCC) from Equal-Weight to Overweight and raise...

Guggenheim Initiates Coverage On C4 Therap...
09/04/2025 14:03:01

Guggenheim analyst Brad Canino initiates coverage on C4 Therapeutics (NASDAQ:CCCC) with a Buy rating and announces Price Tar...

C4 Therapeutics Highlights Biogen Collabor...
09/04/2025 11:26:02

12 Health Care Stocks Moving In Thursday's...
08/07/2025 17:09:32

C4 Therapeutics Q2 EPS $(0.37) Beats $(0.4...
08/07/2025 11:13:11

C4 Therapeutics (NASDAQ:CCCC) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.4...

C4 Therapeutics' Cash, Cash Equivalents An...
05/07/2025 11:15:54

C4 Therapeutics Q1 2025 EPS $(0.37) Beats ...
05/07/2025 11:14:53

C4 Therapeutics Announces 2025 Milestones ...
01/14/2025 12:02:04